Ryuji Kanno

Ryuji Kanno

Director/Board Member presso JEOL LTD.

74 anni
Health Technology
Electronic Technology
Consumer Services

Profilo

Ryuji Kanno is currently an Outside Director at JEOL Ltd., a Director at Human Metabolome Technologies America, Inc., a Director at HMT Biomedical KK, and a Director at Human Metabolome Technologies Europe, B.V.
He was formerly the Chairman of Human Metabolome Technologies, Inc. from 2019 to 2020.
He also held non-executive director positions at Rigaku Corp.
and principal positions at HP, Inc. and Agilent Technologies Japan Ltd.
Kanno received his undergraduate degree from Tokyo University of Science in 1973.

Posizioni attive di Ryuji Kanno

SocietàPosizioneInizio
JEOL LTD. Director/Board Member 25/06/2021
Director/Board Member 01/10/2012
Director/Board Member 01/01/2016
Human Metabolome Technologies Europe, B.V Director/Board Member 01/05/2017
Tutte le posizioni attive di Ryuji Kanno

Precedenti posizioni note di Ryuji Kanno

SocietàPosizioneFine
HUMAN METABOLOME TECHNOLOGIES, INC. President 21/09/2019
Director/Board Member -
Agilent Technologies Japan Ltd. Corporate Officer/Principal -
HP INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Ryuji Kanno

Formazione di Ryuji Kanno

Tokyo University of Science Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ryuji Kanno

Relazioni

39

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
HP INC.

Electronic Technology

JEOL LTD.

Health Technology

HUMAN METABOLOME TECHNOLOGIES, INC.

Health Technology

Aziende private5

Health Technology

Agilent Technologies Japan Ltd.

Health Services

Health Technology

Human Metabolome Technologies Europe, B.V

Vedi le connessioni aziendali